Selenophene-Containing Inhibitors of Type IIA Bacterial Topoisomerases

Journal of Medicinal Chemistry
2011.0

Abstract

We investigated compounds related to the previously reported antistaphyloccocal agent AVE6971 in an effort to attenuate inhibition of hERG potassium channel current that has been noted for this and related antibacterial drug classes. While most modifications of the original thiophene group compromised antibacterial activity, one selenophene analogue displayed (i) improved activity against the primary target enzyme DNA gyrase, (ii) similar activities against a panel of MRSA clinical isolates, and (iii) reduced hERG channel inhibition.

Knowledge Graph

Similar Paper

Selenophene-Containing Inhibitors of Type IIA Bacterial Topoisomerases
Journal of Medicinal Chemistry 2011.0
Design, Synthesis, and Characterization of Novel Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Potent Anti-Gram-Positive Activity
Journal of Medicinal Chemistry 2013.0
Novel quinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Bioorganic & Medicinal Chemistry Letters 2013.0
Novel N-Linked Aminopiperidine Inhibitors of Bacterial Topoisomerase Type II with Reduced pK<sub>a</sub>: Antibacterial Agents with an Improved Safety Profile
Journal of Medicinal Chemistry 2012.0
Left-Hand Side Exploration of Novel Bacterial Topoisomerase Inhibitors to Improve Selectivity against hERG Binding
ACS Medicinal Chemistry Letters 2015.0
Synthesis and anti-staphylococcal activity of novel bacterial topoisomerase inhibitors with a 5-amino-1,3-dioxane linker moiety
Bioorganic &amp; Medicinal Chemistry Letters 2018.0
Novel bacterial topoisomerase inhibitors derived from isomannide
European Journal of Medicinal Chemistry 2020.0
Novel 3-fluoro-6-methoxyquinoline derivatives as inhibitors of bacterial DNA gyrase and topoisomerase IV
Bioorganic &amp; Medicinal Chemistry Letters 2017.0
Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with In Vivo Efficacy against MRSA
Journal of Medicinal Chemistry 2021.0
New Alkaloid Antibiotics That Target the DNA Topoisomerase I of Streptococcus pneumoniae
Journal of Biological Chemistry 2011.0